首页> Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis> Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis.

Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Samuel,Rubinstein

第一单位： a Department of Internal Medicine , Vanderbilt University Medical Center , Nashville , TN , USA.

作者： Samuel,Rubinstein ^[1] ; Robert F,Cornell ^[2] ; Liping,Du ^[3] ; Beatrice,Concepcion ^[4] ; Stacey,Goodman ^[2] ; Shelton,Harrell ^[2] ; Sara,Horst ^[5] ; Daniel,Lenihan ^[6] ; David,Slosky ^[7] ; Agnes,Fogo ^[8] ; Anthony,Langone ^[4]

作者单位： a Department of Internal Medicine , Vanderbilt University Medical Center , Nashville , TN , USA. ^[1] b Division of Hematology and Oncology, Department of Internal Medicine , Vanderbilt University Medical Center , Nashville , TN , USA. ^[2] c Department of Biostatistics , Vanderbilt University , Nashville , TN , USA. ^[3] d Division of Nephrology, Department of Internal Medicine , Vanderbilt University Medical Center , Nashville , TN , USA. ^[4] e Division of Gastroenterology, Department of Internal Medicine , Vanderbilt University Medical Center , Nashville , TN , USA. ^[5] f Division of Cardiovascular Medicine, Department of Internal Medicine , Vanderbilt Heart and Vascular Institute , Nashville , TN , USA. ^[6] g Vanderbilt University Medical Center , Nashville , TN , USA. ^[7] h Department of Pathology , Vanderbilt University Medical Center , Nashville , TN , USA. ^[8]

关键词 AL amyloidosis end-stage kidney disease kidney biopsy nephrotic syndrome